Experimental diets dictate the metabolic benefits of probiotics in obesity

References

• World Health Organization (WHO). Obesity and overweight fact sheet. http://www.who.int/mediacentre/factsheets/fs311/en/(2016).
   Google Scholar
• Kivimäki M, Kuosma E, Ferrie JE, Luukkonen R, Nyberg ST, Alfredsson L, Batty GD, Brunner EJ, Fransson E, Goldberg M, et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe. Lancet Public Heal. 2017;2:e277–20. doi:10.1016/S2468-2667(17)30074-9.
   PubMed Web of Science ®Google Scholar
• Fonseca VA. Defining and characterizing the progression of type 2 diabetes. Diabetes Care. 2009;32:S151–156. doi:10.2337/dc09-S301.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389:2239–2251. doi:10.1016/S0140-6736(17)30058-2.
   PubMed Web of Science ®Google Scholar
• Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51:679–689. doi:10.1002/hep.23280.
   PubMed Web of Science ®Google Scholar
• Eslam M, Sanyal AJ, George J, Sanyal A, Neuschwander-Tetri B, Tiribelli C, Kleiner DE, Brunt E, Bugianesi E, Yki-Järvinen H, et al. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158:1999–2014.e1. doi:10.1053/j.gastro.2019.11.312.
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84. doi:10.1002/hep.28431.
   PubMed Web of Science ®Google Scholar
• Hall KD, Guo J. Obesity energetics: body weight regulation and the effects of diet composition. Gastroenterology. 2017;152:1718–1727.e3. doi:10.1053/j.gastro.2017.01.052.
   PubMed Web of Science ®Google Scholar
• Stunkard AJ, Harris JR, Pedersen NL, McClearn GE. The body-mass index of twins who have been reared apart. N Engl J Med. 1990;322:1483–1487. doi:10.1056/NEJM199005243222102.
   PubMed Web of Science ®Google Scholar
• Tyrrell J, et al. Height, body mass index, and socioeconomic status: mendelian randomisation study in UK Biobank. BMJ. 2016;352:i582. doi:10.1136/bmj.i582.
   PubMedGoogle Scholar
• Venditti EM, Bray GA, Carrion-Petersen ML, Delahanty LM, Edelstein SL, Hamman RF, Hoskin MA, Knowler WC, Ma Y. First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes. Int J Obes. 2008;32:1537–1544. doi:10.1038/ijo.2008.134.
   PubMed Web of Science ®Google Scholar
• Varkevisser RDM, van Stralen MM, Kroeze W, Ket JCF, Steenhuis IHM. Determinants of weight loss maintenance: a systematic review. Obes Rev. 2019;20:171–211. doi:10.1111/obr.12772.
   PubMed Web of Science ®Google Scholar
• Thonusin C, Shinlapawittayatorn K, Chattipakorn SC, Chattipakorn N. The impact of genetic polymorphisms on weight regain after successful weight loss. Br J Nutr. 2020;124:809–823. doi:10.1017/S0007114520001968.
   PubMed Web of Science ®Google Scholar
• Dulloo AG, Montani J-P. Pathways from dieting to weight regain, to obesity and to the metabolic syndrome: an overview. Obes Rev. 2015;16:1–6. doi:10.1111/obr.12250.
   PubMed Web of Science ®Google Scholar
• Khalil H, Ellwood L, Lord H, Fernandez R. Pharmacological treatment for obesity in adults: an umbrella review. Ann Pharmacother. 2020;54:691–705. doi:10.1177/1060028019898912.
   PubMed Web of Science ®Google Scholar
• Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and risks of bariatric surgery in adults. JAMA. 2020;324:879. doi:10.1001/jama.2020.12567.
   PubMed Web of Science ®Google Scholar
• FAO/WHO. Probiotics in food - Health and nutritional properties and guidelines for evaluation. Report of a Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacter. (2001).
   Google Scholar
• Delzenne NM, Neyrinck AM, Bäckhed F, Cani PD. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol. 2011;7:639–646. doi:10.1038/nrendo.2011.126.
   PubMed Web of Science ®Google Scholar
• Wiciński M, Gębalski J, Gołębiewski J, Malinowski B. Probiotics for the treatment of overweight and obesity in humans—a review of clinical trials. Microorganisms. 2020;8:1148. doi:10.3390/microorganisms8081148.
   PubMed Web of Science ®Google Scholar
• The lancet gastroenterology & hepatology. Probiotics: elixir or empty promise? Lancet Gastroenterol Hepatol. 2019; 4: 81. doi:10.1016/S2468-1253(18)30415-1.
   PubMed Web of Science ®Google Scholar
• Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, et al. Expert consensus document: the international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11:506–514. doi:10.1038/nrgastro.2014.66.
   PubMed Web of Science ®Google Scholar
• Krautkramer KA, Fan J, Bäckhed F. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol. 2020;77–94. doi:10.1038/s41579-020-0438-4.
   PubMed Web of Science ®Google Scholar
• Spencer CN, McQuade JL, Gopalakrishnan V, McCulloch JA, Vetizou M, Cogdill AP, Khan MAW, Zhang X, White MG, Peterson CB, et al. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science. 2021;374:1632–1640. doi:10.1126/science.aaz7015.
   PubMed Web of Science ®Google Scholar
• Zmora N, Zilberman-Schapira G, Suez J, Mor U, Dori-Bachash M, Bashiardes S, Kotler E, Zur M, Regev-Lehavi D, Brik RBZ, et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell. 2018;174:1388–1405.e21. doi:10.1016/j.cell.2018.08.041.
   PubMed Web of Science ®Google Scholar
• Reid G, Gaudier E, Guarner F, Huffnagle GB, Macklaim JM, Munoz AM, Martini M, Ringel-Kulka T, Sartor BR, Unal RR, et al. Responders and non-responders to probiotic interventions. Gut Microbes. 2010;1:200–204. doi:10.4161/gmic.1.3.12013.
   PubMed Web of Science ®Google Scholar
• Ohland CL, Kish L, Bell H, Thiesen A, Hotte N, Pankiv E, Madsen KL. Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome. Psychoneuroendocrinology. 2013;38:1738–1747. doi:10.1016/j.psyneuen.2013.02.008.
   PubMed Web of Science ®Google Scholar
• Tachon S, Lee B, Marco ML. Diet alters probiotic Lactobacillus persistence and function in the intestine. Environ Microbiol. 2014;16:2915–2926. doi:10.1111/1462-2920.12297.
   PubMed Web of Science ®Google Scholar
• Kovatcheva-Datchary P, Nilsson A, Akrami R, Lee Y, De Vadder F, Arora T, Hallen A, Martens E, Björck I, Bäckhed F. Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of prevotella. Cell Metab. 2015;22:971–982. doi:10.1016/j.cmet.2015.10.001.
   PubMed Web of Science ®Google Scholar
• Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BAH, Forslund K, Hildebrand F, Prifti E, Falony G, et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016;535:376–381. doi:10.1038/nature18646.
   PubMed Web of Science ®Google Scholar
• Damgaard MTF, Pærregaard SI, Søgaard I, Agerholm M, Paulson JN, Treebak JT, Sina C, Holm JB, Kristiansen K, Jensen BAH. Age-dependent alterations of glucose clearance and homeostasis are temporally separated and modulated by dietary fat. J Nutr Biochem. 2018;54. doi:10.1016/j.jnutbio.2017.09.026.
   PubMed Web of Science ®Google Scholar
• Chong J, Wishart DS, Xia J. Using MetaboAnalyst 4.0 for comprehensive and integrative metabolomics data analysis. Curr Protoc Bioinforma. 2019;68:1–128. doi:10.1002/cpbi.86.
   Google Scholar
• Liang W, Menke AL, Driessen A, Koek GH, Lindeman JH, Stoop R, Havekes LM, Kleemann R, van den Hoek AM. Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology. Plos One. 2014;9:1–17. doi:10.1371/journal.pone.0115922.
   Web of Science ®Google Scholar
• Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RNM, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696–699. doi:10.1016/0168-8278(95)80226-6.
   PubMed Web of Science ®Google Scholar
• Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol. 2007;47:598–607. doi:10.1016/j.jhep.2007.07.006.
   PubMed Web of Science ®Google Scholar
• Klindworth A, Pruesse E, Schweer T, Peplies J, Quast C, Horn M, Glöckner FO. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2013;41:1–11. doi:10.1093/nar/gks808.
   PubMed Web of Science ®Google Scholar
• Larsen IS, Jensen BAH, Bonazzi E, Choi BSY, Kristensen NN, Schmidt EGW, Süenderhauf A, Morin L, Olsen PB, Hansen LBS, et al. Fungal lysozyme leverages the gut microbiota to curb DSS-induced colitis. Gut Microbes. 2021;13. doi:10.1080/19490976.2021.1988836.
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289–300. doi:10.1111/j.2517-6161.1995.tb02031.x.
   Web of Science ®Google Scholar
• Kuznetsova A, Brockhoff PB, Christensen RHB. lmerTest package: tests in linear mixed effects models. J Stat Softw. 2017;82:1–26. doi:10.18637/jss.v082.i13.
   Web of Science ®Google Scholar
• Oksanen J, et al. Vegan: community ecology package. R Packag. ver. 2.4–3. 2017. 10.4135/9781412971874.n145.
   Google Scholar
• Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2014;67. doi:10.18637/jss.v067.i01.
   Web of Science ®Google Scholar
• Tandra S, Yeh MM, Brunt EM, Vuppalanchi R, Cummings OW, Ünalp-Arida A, Wilson LA, Chalasani N. Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease. J Hepatol. 2011;55:654–659. doi:10.1016/j.jhep.2010.11.021.
   PubMed Web of Science ®Google Scholar
• Chassaing B, Miles-Brown J, Pellizzon M, Ulman E, Ricci M, Zhang L, Patterson AD, Vijay-Kumar M, Gewirtz AT. Lack of soluble fiber drives diet-induced adiposity in mice. Am J Physiol - Gastrointest Liver Physiol. 2015;309:G528–541. doi:10.1152/ajpgi.00172.2015.
   PubMed Web of Science ®Google Scholar
• Daniel N, Rossi Perazza L, Varin TV, Trottier J, Marcotte B, St-Pierre P, Barbier O, Chassaing B, Marette A. Dietary fat and low fi ber in puri fi ed diets differently impact the gut-liver axis to promote obesity-linked metabolic impairments. Am J Physiol Gastrointest Liver Physiol. 2021;320. doi:10.1152/ajpgi.00028.2021.
   PubMed Web of Science ®Google Scholar
• Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, Luo G, Jones SA, Goodwin B, Richardson JA, et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2005;2:217–225. doi:10.1016/j.cmet.2005.09.001.
   PubMed Web of Science ®Google Scholar
• Lu M, Sun J, Zhao Y, Zhang H, Li X, Zhou J, Dang H, Zhang J, Huang W, Qi C, et al. Prevention of high-fat diet-induced hypercholesterolemia by lactobacillus reuteri Fn041 through promoting cholesterol and bile salt excretion and intestinal mucosal barrier functions. Front Nutr. 2022;9:1–14. doi:10.3389/fnut.2022.851541.
   Web of Science ®Google Scholar
• Zhang C, Fang R, Lu X, Zhang Y, Yang M, Su Y, Jiang Y, Man C. Lactobacillus reuteri J1 prevents obesity by altering the gut microbiota and regulating bile acid metabolism in obese mice. Food Funct. 2022;13:6688–6701. doi:10.1039/D1FO04387K.
   PubMed Web of Science ®Google Scholar
• Qiu J-F, Zhang K-L, Zhang X-J, Hu Y-J, Li P, Shang C-Z, Wan J-B. Abnormalities in plasma phospholipid fatty acid profiles of patients with hepatocellular carcinoma. Lipids. 2015;50:977–985. doi:10.1007/s11745-015-4060-6.
   PubMed Web of Science ®Google Scholar
• Vlock EM, Karanjit S, Talmon G, Farazi PA. Reduction of polyunsaturated fatty acids with tumor progression in a lean non-alcoholic steatohepatitis- associated hepatocellular carcinoma mouse model. J Cancer. 2020;11:5536–5546. doi:10.7150/jca.48495.
   PubMed Web of Science ®Google Scholar
• Paik D, Yao L, Zhang Y, Bae S, D’agostino GD, Zhang M, Kim E, Franzosa EA, Avila-Pacheco J, Bisanz JE, et al. Human gut bacteria produce ΤΗ17-modulating bile acid metabolites. Nature. 2022. doi:10.1038/s41586-022-04480-z.
   PubMed Web of Science ®Google Scholar
• Campbell C, McKenney PT, Konstantinovsky D, Isaeva OI, Schizas M, Verter J, Mai C, Jin W-B, Guo C-J, Violante S, et al. Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells. Nature. 2020. doi:10.1038/s41586-020-2193-0.
   Web of Science ®Google Scholar
• Jensen BAH, Holm JB, Larsen IS, von Burg N, Derer S, Sonne SB, Pærregaard SI, Damgaard MV, Indrelid SA, Rivollier A, et al. Lysates of Methylococcus capsulatus Bath induce a lean-like microbiota, intestinal FoxP3+RORγt+IL-17+ Tregs and improve metabolism. Nat Commun. 2021;12. doi:10.1038/s41467-021-21408-9.
   Web of Science ®Google Scholar
• Litvak Y, Byndloss MX, Tsolis RM, Bäumler AJ. Dysbiotic Proteobacteria expansion: a microbial signature of epithelial dysfunction. Curr Opin Microbiol. 2017;39:1–6. doi:10.1016/j.mib.2017.07.003.
   PubMed Web of Science ®Google Scholar
• Zhu L, Baker SS, Gill C, Liu W, Alkhouri R, Baker RD, Gill SR. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology. 2013;57:601–609. doi:10.1002/hep.26093.
   PubMed Web of Science ®Google Scholar
• Anhê FF, Jensen BAH, Varin TV, Servant F, Van Blerk S, Richard D, Marceau S, Surette M, Biertho L, Lelouvier B, et al. Type 2 diabetes influences bacterial tissue compartmentalisation in human obesity. Nat Metab. 2020. doi:10.1038/s42255-020-0178-9.
   PubMedGoogle Scholar
• Massier L, Chakaroun R, Tabei S, Crane A, Didt KD, Fallmann J, von Bergen M, Haange S-B, Heyne H, Stumvoll M, et al. Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes. Gut. 2020:1–11. doi:10.1136/gutjnl-2019-320118
   Web of Science ®Google Scholar
• Kristensen NB, Bryrup T, Allin KH, Nielsen T, Hansen TH, Pedersen O. Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med. 2016;8(1). doi:10.1186/s13073-016-0300-5.
   PubMedGoogle Scholar